Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Parkinson's Disease Modeling

Parkinson's Disease (PD) is a movement disorder caused by the degeneration of dopaminergic neurons. Common experimental models include the MPTP-induced model, 6-OHDA lesion model, and 伪-synuclein transgenic models. These models are widely used to study pathogenic mechanisms such as mitochondrial dysfunction, neuroinflammation, and 伪-synuclein aggregation, as well as to explore therapeutic intervention strategies.

mptp hydrochloride
T408123007-85-4
MPTP hydrochloride is a precursor of MPP+, a dopamine neurotoxin with blood-brain barrier permeability. MPTP hydrochloride is toxic to dopaminergic neurons, which can lead to Parkinson's disease, and is widely used in the construction of animal models of Parkinson's disease.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Hot
rotenone
T297083-79-4
Rotenone (Rotocide) is a natural product and a botanical insecticide. Rotenone is a mitochondrial electron transport complex I inhibitor that promotes the production of reactive oxygen species in mitochondria and induces apoptosis.
  • $42
In Stock
Size
QTY
TargetMol | Citations Cited
Oxidopamine hydrobromide
T12352L636-00-0
Oxidopamine hydrobromide (6-OHDA hydrobromide) is a neurotransmitter dopamine antagonist.
  • $56
In Stock
Size
QTY
TargetMol | Citations Cited
L-DOPA
T084859-92-7
L-DOPA (Levodopa) is an amino acid precursor of dopamine with antiparkinsonian properties. It is a prodrug converted to dopamine by DOPA decarboxylase and can cross the blood-brain barrier. In the brain, levodopa is decarboxylated to dopamine, stimulating dopaminergic receptors and compensating for depleted endogenous dopamine in Parkinson's disease. To ensure adequate concentrations reach the central nervous system, levodopa is administered with carbidopa, a decarboxylase inhibitor that does not cross the blood-brain barrier, reducing peripheral decarboxylation and increasing CNS dopamine delivery.
  • $50
In Stock
Size
QTY
TargetMol | Citations Cited
Oxidopamine hydrochloride
T1235228094-15-7
Oxidopamine hydrochloride (6-Hydroxydopamine hydrochloride) is an neurotransmitter dopamine antagonist.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Haloperidol
T002552-86-8
Haloperidol (Serenace) is a highly potent neuroleptic by relieving nervous through the depression of nerve function. In addition, haloperidol has shown about 50-fold efficacy than chlorpromazine, another antipsychotic drug. Haloperidol has some potencies in the treatment of delusions and hallucinations. Its effects are primarily attained through blocking dopamine receptors in the mesocortex and limbic system.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
Lactacystin
T15702133343-34-7
Lactacystin is a natural non-peptide proteasome inhibitor and highly specific anticancer drug that controls the UPS of cellular protein turnover and inhibits alkaline cell proliferation, and is able to be used as a model for studying dementia, induces neurite outgrowth and transiently elevated levels of cAMP, inhibits angiogenesis, triggers apoptosis in glioma cells, and can penetrate the blood-brain barrier (BBB).
  • TBD
In Stock
Size
QTY
Levodopa sodium
T3270163302-01-2
Levodopa is the naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier, and rapidly taken up by dopaminergic neurons and converted to D
  • Inquiry Price
Size
QTY